Results 71 to 80 of about 31,041 (297)
Molecular Docking and Target‐Specific Binding Profiles of Benzosuberane‐Based Compounds
Benzosuberane represents a promising scaffold in medicinal chemistry. Several benzosuberane‐based derivatives are described in this review as anticancer agents, including antivascular agents, DNA‐intercalators, receptor modulators and kinase inhibitors.
Michail A. Saragatsis +3 more
wiley +1 more source
Interventions in structural heart disease cover many catheter-based procedures for congenital and acquired conditions including valvular diseases, septal defects, arterial or venous obstructions, and fistulas.
Andreas Mitsis +4 more
doaj +1 more source
Antiplatelets in secondary stroke prevention
The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention.
Olga eShulga, Natan eBornstein
doaj +1 more source
Treatment of Thrombotic Thrombocytopenic Purpura With Antiplatelet Drugs [PDF]
Jacob Amir, Stephen Krauss
openalex +1 more source
Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu +21 more
wiley +1 more source
EFFECTIVE USE OF ANTIPLATELETS AFTER RECONSTRUCTIVE OPERATIONS
Treatment of chronic obliterating peripheral arterial disease (PAD) and the resulting chronic ischemia of the lower extremities is at the moment one of the most urgent problems in vascular surgery.
D. V. Krylov +3 more
doaj +1 more source
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez +5 more
wiley +1 more source
Effect of heterologous antiplatelet antibody on human platelets: a new pathway to platelet alteration [PDF]
RW Colman, J Kuchibhotla, AD Schreiber
openalex +1 more source
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang +6 more
wiley +1 more source

